What is a multidisciplinary tumor board and should my Sarcoma case be presented
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Multidisciplinary Tumor Boards for Sarcoma
What Is a Multidisciplinary Tumor Board?
A multidisciplinary tumor board (often called a "tumor conference" or "case conference") is a meeting where a team of cancer specialists from different medical fields reviews and discusses individual patient cases together. Think of it as a "huddle" of experts who each bring their own perspective to help plan the best treatment approach.
The typical team includes:
- Surgical oncologists (surgeons who specialize in cancer)
- Medical oncologists (doctors who prescribe chemotherapy and other systemic treatments)
- Radiation oncologists (specialists in radiation therapy)
- Pathologists (experts who examine tissue samples under microscopes)
- Radiologists (specialists who interpret imaging like CT scans and MRIs)
- Nurses and other support staff
Each specialist reviews your imaging, pathology report, and medical history, then the group discusses the best treatment options for YOUR specific situation.
Should Your Sarcoma Case Be Presented?
Yes—strongly. According to the NCCN Guidelines for Soft Tissue Sarcoma, multidisciplinary evaluation is essential for sarcoma care:
"Multidisciplinary evaluation involving pediatric, medical, surgical, and radiation oncologists is strongly encouraged" and "Multimodality treatment planning and risk stratification is required."
This is particularly important for sarcoma because:
Why Sarcoma Needs Multidisciplinary Review:
-
Sarcomas are complex and rare — They come in many different types (leiomyosarcoma, liposarcoma, synovial sarcoma, etc.), and treatment varies significantly based on the specific type, grade, and stage.
-
Treatment requires coordination — Most sarcoma patients need a combination of surgery, radiation, and sometimes chemotherapy. These treatments must be carefully sequenced and coordinated to work together effectively.
-
Location matters greatly — Whether your sarcoma is in an extremity (arm/leg), retroperitoneum (deep abdomen), or other location changes the treatment approach significantly.
-
Preserving function is critical — Sarcoma surgery can affect your ability to use a limb or organ function. The team needs to balance removing all the cancer while minimizing disability.
What Happens During Tumor Board Review?
The team will typically discuss:
- Your pathology findings — What type of sarcoma is it? What grade (how aggressive)?
- Staging — How large is it and has it spread?
- Surgical options — Can it be removed completely? What's the best surgical approach?
- Radiation planning — Do you need radiation? Before or after surgery?
- Systemic therapy — Do you need chemotherapy or other drugs?
- Functional outcomes — How can we treat this while preserving your quality of life?
The goal is to develop a coordinated treatment plan that gives you the best chance of controlling the cancer while maintaining your function and quality of life.
Questions to Ask Your Oncologist
-
"Will my case be presented to a multidisciplinary tumor board?" — If not, ask why and whether it should be.
-
"Who will be involved in planning my treatment?" — Make sure you understand which specialists are part of your care team.
-
"What does the tumor board recommend for my specific sarcoma type and stage?" — Get clarity on the recommended approach.
-
"Are there any alternative treatment approaches the board discussed?" — Understanding options helps you make informed decisions.
-
"How will my treatment be coordinated between surgery, radiation, and medical oncology?" — This coordination is crucial for sarcoma success.
Bottom Line
For sarcoma patients, multidisciplinary tumor board review isn't optional—it's a standard of care. The NCCN Guidelines emphasize that this coordinated approach is essential for optimal outcomes. If your care team hasn't mentioned presenting your case to a tumor board, it's absolutely appropriate to ask about it.
According to the NCCN Guidelines, "Referral to institutions with expertise in treating patients with [sarcoma] is strongly recommended." If you're not at a major cancer center with sarcoma expertise, you might also ask whether your case could be reviewed at a specialized sarcoma center.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Soft Tissue Sarcoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Sarcoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: